Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Converge Coverage

  • News

    Remdesivir sharply cuts COVID hospitalization risk, Gilead says

    September 23, 2021

    An RCT evaluated the efficacy and safety of a 3-day course of intravenous remdesivir in an analysis of 562 nonhospitalized patients at high risk for disease progression.

  • 1
    News

    EMPEROR-Preserved: Empagliflozin’s HFpEF efficacy catalyzes a heart failure redefinition

    September 20, 2021

    Cardiologists have long defined heart failure as involving reduced or preserved ejection fraction. Results from big empagliflozin trials say forget that.

  • News

    Poor lung function linked to risk for sudden cardiac death

    September 16, 2021

    Every standard deviation decrease in forced expiratory volume in 1 second (FEV1) was associated with a 23% increase in risk for sudden cardiac death.

  • 1
    News

    PRESERVED-HF: Dapagliflozin improves physical limitations in patients with HFpEF

    September 14, 2021

    The SGLT2 inhibitor dapagliflozin boosted KCCQ scores and 6-minute walk distance in HFpEF patients in a 324-patient randomized trial.

  • News

    COVID-19 spares lung function in young adults

    September 10, 2021

    “We found no effect of COVID-19 on spirometric lung function in generally healthy adults.”

  • News

    Growing proportion of cardiac arrests in U.S. considered opioid related

    September 10, 2021

    Due to a steep rise, opioid-associated cardiac arrests have become a major public health issue.

  • News

    Medical education must takes broader view of disabilities

    September 9, 2021

    Strategies for disability education can help health care providers reduce disparities in care for the disabled.

  • 1
    News

    Choosing Wisely campaign targets waste and overuse in hospital pediatrics

    September 8, 2021

    Multiple medical societies collaborated to develop guidelines for high-value care with less unnecessary testing and hospitalization.

  • 1
    News

    COVID-19 continues to complicate children’s mental health care

    September 8, 2021

    One pediatric hospital’s strategies for managing medical and mental health in the wake of the ongoing pandemic.

  • News

    ‘Lopioid protocol’ – low-dose opioids – proposed for fracture surgery

    September 3, 2021

    “Managing narcotics postoperatively can be challenging due to the fact that many people come into these fractures with a history of narcotic use.”

Previous1 … 11 12 13 14 15 … 105Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences